financing

Centerra Gold invests C$10M in Nevada King for 9.9% stake, funding Atlanta Gold Mine exploration in Nevada through C$16M private placement closing Q2 2026.

i-80 Gold closes $250M gold prepayment facility and completes $1B+ recapitalization, fully funding development through 2031 production targets.

Tenon Medical reports 92% Q4 revenue growth to $1.5M, achieves 69% gross margins, secures FDA clearance and $4.3M financing for spine fusion device expansion.

$CRIS reports $19.4M Q4 earnings from one-time Erivedge sale; refocuses on PCNSL and CLL studies with $20.2M PIPE funding.

NexGel acquires regenerative biomaterial portfolio from Celularity, expecting to nearly triple 2026 revenue to $35M and achieve immediate profitability.

Diana Shipping increases all-cash offer for Genco Shipping to $23.50/share, a 31% premium, with $1.433B in committed financing and Star Bulk's vessel purchase agreement.

Rallybio soars as merger with $505M-backed Candid Therapeutics creates combined biotech with $700M cash runway through 2030.

Juggernaut Exploration raises C$10M through flow-through private placement to fund exploration of its Big One Gold Project in British Columbia's Golden Triangle.

ContextLogic completes $907.5M acquisition of US Salt, pivoting from e-commerce to a business ownership platform model with new institutional investors.

Ideal Power raised $14M to commercialize its B-TRAN semiconductor technology, funding customer design-ins, partnerships, and production infrastructure.

Ideal Power raises $14M through mixed equity financing to accelerate commercialization of its B-TRAN semiconductor technology and expand customer design-ins.

CoreWeave shares fell after reports of Blue Owl Capital's data center financing struggles. Both companies denied funding shortfalls, but the market reaction highlights investor concerns about AI infrastructure financing.

Green Thumb Industries expanded its credit facility to $189M with a $50M commitment from Valley National Bank, enhancing financial flexibility for operations and capital allocation.

Inventiva raises $172.5M, boosting cash position to €99.3M and extending runway through mid-2027 to fund MASH therapy development.